ArticleThe oncologist2021

Gefitinib Combined with Cetuximab for the Treatment of Lung Adenocarcinoma Harboring the EGFR-Intergenic Region (SEC61G) Fusion and EGFR Amplification.

Guoqing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.